What is Retina Associates?
Established in 1991, Retina Associates operates as a specialized medical practice dedicated to the management of complex diseases and surgery of the retina and vitreous. The firm distinguishes itself through a dual commitment to compassionate patient care and rigorous scientific investigation. By integrating state-of-the-art diagnostic instrumentation—including advanced angiography and computerized tomography—with a robust clinical research program, the company addresses critical conditions such as macular degeneration, diabetic retinopathy, and retinal detachment. Their model combines high-volume surgical expertise with academic-level physician training, positioning them as a cornerstone of ophthalmological health in the Midwest.
How much funding has Retina Associates raised?
Retina Associates has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Retina Associates
PPP
Public-Private Partnership
What's next for Retina Associates?
The infusion of capital from this late-stage financing round is expected to accelerate the firm's strategic initiatives in clinical trial participation and technological infrastructure upgrades. As the company navigates the evolving landscape of specialized ophthalmology, the focus will likely shift toward expanding its footprint of fully equipped diagnostic offices and deepening its involvement in pioneering vitreo-retinal research. By leveraging this financial backing, Retina Associates is well-positioned to enhance its surgical outcomes and maintain its leadership in the treatment of sight-threatening disorders, ensuring that its patient-centric model remains at the forefront of medical innovation.
See full Retina Associates company page
